Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Kamada Ltd. (NASDAQ: KMDA), an Israeli-based healthcare company in the Drug Manufacturers – Specialty & Generic industry, is capturing investor attention with its significant upside potential. With a market capitalization..
Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is drawing attention from investors with its significant potential upside of 311.11%, according to current analyst ratings. With a market cap of..
Stoke Therapeutics, Inc. (NASDAQ: STOK) stands at the forefront of biotechnology innovation with a focus on severe genetic diseases. The company, which emerged in 2014 and rebranded in 2016, is..
Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector, is garnering attention for its notable potential upside of 34.46%. As a company specializing in preparedness and response..
Nutex Health Inc. (NUTX) is making waves in the healthcare sector, particularly within the medical care facilities industry. With its headquarters in Houston, Texas, Nutex Health operates a diverse portfolio..
In the ever-evolving landscape of biotechnology, Arbutus Biopharma Corporation (NASDAQ: ABUS) emerges as a noteworthy contender with its focus on innovative therapeutics for infectious diseases. With a market capitalization of..
Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector, is making waves in the medical care facilities industry. Based in Dallas, Texas, Sonida operates senior housing communities..
Investors with a keen interest in biotech innovation should keep an eye on REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology firm pioneering gene therapies. With a market capitalization of $614.76..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing the attention of investors with its promising pipeline in the biotechnology sector. As a clinical-stage biopharmaceutical company, Oric is committed to developing therapies..
Prothena Corporation plc (NASDAQ: PRTA), a pioneering biotech entity headquartered in Dublin, Ireland, is making strategic strides in the healthcare sector, specifically within the biotechnology industry. With a current market..
Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, offers a compelling investment opportunity with a potential upside of 98.02%. This potential is driven by an..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is capturing the attention of investors with its promising outlook in the biotech sector. As a clinical-stage pharmaceutical company, Amylyx is focused on developing treatment..
Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent player in the healthcare sector, specializes in molecular diagnostic testing and precision medicine. With a market capitalization of $720.17 million, this Salt Lake..
Treace Medical Concepts, Inc. (NASDAQ: TMCI) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. As a U.S.-based company with a market capitalization of approximately..
Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical innovator from the United Kingdom, has captured the attention of investors with its promising pipeline of T cell therapies targeting cancer and..
OrthoPediatrics Corp. (NASDAQ: KIDS) has positioned itself as a pivotal player in the healthcare sector, particularly within the niche market of pediatric orthopedic medical devices. Headquartered in Warsaw, Indiana, this..
Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company, has caught the attention of investors with its impressive potential upside of 271.95%. This Massachusetts-based firm, specializing in developing therapies for..
Gyre Therapeutics, Inc. (NASDAQ: GYRE), a promising player in the biotech sector, is attracting significant attention from investors with its remarkable potential for growth. With a current market cap of..
Claritev Corporation (NASDAQ: CTEV), a prominent player in the healthcare information services sector, has been capturing investor attention with its innovative solutions aimed at reducing healthcare costs and improving operational..
Niagen Bioscience, Inc. (NAGE), a prominent player in the biotechnology industry, is attracting the attention of investors with its impressive potential upside of 112.17%. Specializing in developing healthy aging products,..
